Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Depression: Overview01:18

Depression: Overview

669
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
669
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

355
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
355
Long-term Depression01:03

Long-term Depression

2.9K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
2.9K
Long-term Depression01:05

Long-term Depression

32.9K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
32.9K
Stress and Mental Health01:30

Stress and Mental Health

423
Chronic stress profoundly affects mental health, significantly influencing mood, behavior, and overall quality of life. Research closely links chronic stress with mental health conditions such as depression, anxiety, and substance use disorders. Ongoing exposure to stress can lead to physiological and psychological changes, initiating a cycle of emotional distress and maladaptive coping mechanisms.
Individuals with depression often experience challenges in both their personal and professional...
423
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

459
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
459

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Question: Why Is My Patient With Breast Cancer Advised That She Can Take Clozapine and Tamoxifen Together Despite Possible Interactions Between the Two?

Journal of clinical psychopharmacology·2026
Same author

Nathan S. Kline: From the first treatments of psychosis and depression, a 70-year legacy of a pioneer of psychopharmacology.

Journal of psychopharmacology (Oxford, England)·2026
Same author

Karl Rickels, MD: A 100-Year Journey.

Journal of clinical psychopharmacology·2026
Same author

Question: How Is it Possible That Phenelzine Combined With Dextromethorphan Could Cause Serotonin Syndrome?

Journal of clinical psychopharmacology·2026
Same author

Time Trends in Prescribing of Anxiolytic, Sedative, and Hypnotic Drugs in the United States.

Clinical therapeutics·2026
Same author

Question: Should I be Advising My Patients to Drink More Lithium-Containing Bottled Water to Possibly Prevent Alzheimer Disease?

Journal of clinical psychopharmacology·2025
Same journal

Reimagining Representation Across the Clinical Research Ecosystem: Part II of a Specialty Update on Advancing Diversity, Racial Equity, and Inclusion in Clinical Research.

Clinical therapeutics·2026
Same journal

Combined Effects of Nicorandil and Enhanced External Counterpulsation on Coronary Microcirculation and Exercise Capacity in Patients With Coronary Slow Flow Phenomenon: A Randomized, Controlled, 3-Arm Trial.

Clinical therapeutics·2026
Same journal

Phase 1 Study Evaluating Gefurulimab Pharmacokinetics and Safety Following Delivery Via Autoinjector or Prefilled Syringe With Needle Safety Device in Healthy Adults.

Clinical therapeutics·2026
Same journal

Evaluating Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Associated With Newer Antiseizure Medications Using FAERS and JADER Combined With Bioinformatics Exploration.

Clinical therapeutics·2026
Same journal

Diversity: A Medical Research Imperative.

Clinical therapeutics·2026
Same journal

LOARGYS (pegzilarginase-nbln).

Clinical therapeutics·2026
See all related articles

Related Experiment Video

Updated: Dec 22, 2025

A New Method for Inducing a Depression-Like Behavior in Rats
07:57

A New Method for Inducing a Depression-Like Behavior in Rats

Published on: February 22, 2018

21.8K

COVID-19 and Depression.

Richard I Shader1

  • 1Tufts University School of Medicine, Boston, MA, United States.

Clinical Therapeutics
|May 5, 2020
PubMed
Summary
This summary is machine-generated.

The COVID-19 pandemic causes significant stress, making it crucial for clinicians to differentiate between demoralization and depression. This commentary offers guidance on distinguishing these conditions and discusses potential treatments, including a warning about certain medications.

Keywords:
COVID-19ChloroquineDemoralizationDepressionHydroxychloroquine

More Related Videos

An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents
06:55

An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents

Published on: December 2, 2015

23.2K
Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
04:33

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

1.1K

Related Experiment Videos

Last Updated: Dec 22, 2025

A New Method for Inducing a Depression-Like Behavior in Rats
07:57

A New Method for Inducing a Depression-Like Behavior in Rats

Published on: February 22, 2018

21.8K
An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents
06:55

An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents

Published on: December 2, 2015

23.2K
Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
04:33

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

1.1K

Area of Science:

  • Mental Health
  • Epidemiology
  • Clinical Medicine

Background:

  • The COVID-19 pandemic has induced widespread psychological distress, including unemployment, loss, and social isolation.
  • Clinicians face challenges in distinguishing between demoralization and depression in affected individuals.
  • The use of specific drugs like chloroquine and hydroxychloroquine for COVID-19 treatment requires careful consideration.

Purpose of the Study:

  • To differentiate the clinical characteristics of demoralization from depression.
  • To propose management strategies for both demoralization and depression in the context of the pandemic.
  • To provide a cautionary note regarding the use of chloroquine and hydroxychloroquine in COVID-19 patients.

Main Methods:

  • This is a commentary, not a primary research study.
  • It involves a review and synthesis of existing knowledge on demoralization and depression.
  • It analyzes the psychological impact of the COVID-19 pandemic.

Main Results:

  • Demoralization and depression present distinct, though sometimes overlapping, symptoms.
  • Effective management requires tailored approaches based on accurate diagnosis.
  • Concerns exist regarding the safety and efficacy of chloroquine and hydroxychloroquine for COVID-19.

Conclusions:

  • Accurate differentiation between demoralization and depression is vital for appropriate patient care during the COVID-19 crisis.
  • Evidence-based treatment strategies should be prioritized.
  • The use of unproven or potentially harmful medications in COVID-19 patients should be approached with extreme caution.